Demographic and clinical characteristics of our BC patient cohort
| Patient ID . | Sex . | Age . | Surgical procedure . | Disease grade . | Disease stage . | Treatment history . | Volume of urine . | Live cells in urine . |
|---|---|---|---|---|---|---|---|---|
| 1 | Male | 74 | TURBT | High-grade UC | NMI, papillary Ta | Naïve | 50 ml | 64.5 × 10e6 |
| 2 | Male | 90 | TURBT | High-grade UC | NMI, papillary Ta | Naïve | 50 ml | 72 × 10e6 |
| 3 | Male | 75 | TURBT | High-grade UC | NMI, papillary T1 | Naïve | 95 ml | 7 × 10e6 |
| 4 | Male | 82 | Cystectomy | High-grade UC with 20% squamous differentiation | MI, papillary T3a | Naïve | 100 ml | 149 × 10e6 |
| 5 | Male | 82 | Cystectomy | Small cell carcinoma (70%), squamous cell (20%), sarcomatoid carcinoma (9%), high-grade UC (1%) | MI, papillary T3b | BCG | 25 ml | 31.8 × 10e6 |
| 6 | Male | 70 | Cystectomy | High-grade UC with squamous differentiation | MI | Naïve | 90 ml | 55 × 10e6 |
| 7 | Male | 64 | TURBT | High-grade UC with squamous differentiation | MI | Pre-/post-chemotherapy treatment | 60 ml; 65 ml | 33 × 10e6; 56 × 10e6 |
| 8 | Male | 62 | Cystectomy | High-grade UC | NMI, carcinoma in situ | Naïve | 30 ml | 2.6 × 10e6 |
| 9 | Female | 63 | TURBT | High-grade UC | NMI | Naïve | 65 ml | 1.66 × 10e6 |
| Patient ID . | Sex . | Age . | Surgical procedure . | Disease grade . | Disease stage . | Treatment history . | Volume of urine . | Live cells in urine . |
|---|---|---|---|---|---|---|---|---|
| 1 | Male | 74 | TURBT | High-grade UC | NMI, papillary Ta | Naïve | 50 ml | 64.5 × 10e6 |
| 2 | Male | 90 | TURBT | High-grade UC | NMI, papillary Ta | Naïve | 50 ml | 72 × 10e6 |
| 3 | Male | 75 | TURBT | High-grade UC | NMI, papillary T1 | Naïve | 95 ml | 7 × 10e6 |
| 4 | Male | 82 | Cystectomy | High-grade UC with 20% squamous differentiation | MI, papillary T3a | Naïve | 100 ml | 149 × 10e6 |
| 5 | Male | 82 | Cystectomy | Small cell carcinoma (70%), squamous cell (20%), sarcomatoid carcinoma (9%), high-grade UC (1%) | MI, papillary T3b | BCG | 25 ml | 31.8 × 10e6 |
| 6 | Male | 70 | Cystectomy | High-grade UC with squamous differentiation | MI | Naïve | 90 ml | 55 × 10e6 |
| 7 | Male | 64 | TURBT | High-grade UC with squamous differentiation | MI | Pre-/post-chemotherapy treatment | 60 ml; 65 ml | 33 × 10e6; 56 × 10e6 |
| 8 | Male | 62 | Cystectomy | High-grade UC | NMI, carcinoma in situ | Naïve | 30 ml | 2.6 × 10e6 |
| 9 | Female | 63 | TURBT | High-grade UC | NMI | Naïve | 65 ml | 1.66 × 10e6 |